GlassScriptPhysician profile
Jonathan Chang
NPI 1104824556
$9,492.84
in general payments reported to CMS, 2019-2025
22 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,324 · 2020: $2,294 · 2021: $527 · 2022: $389 · 2023: $342 · 2024: $598 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Orthopaedic Solutions, INC. | $4,221.11 | 2019-2020 | |
| Amgen INC. | $1,689.23 | 2019-2025 | Evenity, Prolia |
| Stryker Corporation | $591.98 | 2024-2025 | Profyle, T2 Alpha, Gamma |
| Zimmer Biomet Holdings, INC. | $583.15 | 2019-2025 | Oxford |
| Mallinckrodt Enterprises LLC | $389.89 | 2019 | |
| Radius Health, INC. | $378.27 | 2019-2021 | |
| Horizon Therapeutics Plc | $227.98 | 2019-2022 | |
| Conformis, INC. | $222.23 | 2021 | |
| Glaxosmithkline, LLC. | $177.26 | 2023-2025 | Nucala, Trelegy Ellipta |
| Mallinckrodt Hospital Products INC. | $158.94 | 2020 | |
| Bioventus LLC | $148.52 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Medical Device Business Services, INC. | $121.83 | 2019 | |
| Arthrex, INC. | $121.18 | 2021 | |
| Heron Therapeutics, INC. | $109.61 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $95.34 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $63.23 | 2020-2021 | |
| Globus Medical, INC. | $54.95 | 2022 | |
| Orthofix Medical, INC. | $41.00 | 2025 | Physio-Stim |
| Saxum Surgical, INC. | $32.51 | 2023 | |
| Pacira Therapeutics, INC. | $24.38 | 2019 | |
| Vericel Corporation | $23.62 | 2025 | Maci |
| Ferring Pharmaceuticals INC. | $16.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.